Taylor Druzinsky

Taylor Druzinsky is the Associate Director of Program Management at BridgeBio Gene Therapy, where they have held the position since 2023. Taylor previously worked as a Senior Clinical Trial Specialist at Ultragenyx Pharmaceutical Inc. and as a Clinical Project Manager at Zenas BioPharma. They also served as an IRB Coordinator and Clinical Research Associate at Connecticut Children's from 2017 to 2019. Taylor earned a Bachelor of Arts in Speech, Language, and Hearing Sciences from the University of Connecticut in 2017.